- Home
- A-Z Publications
- Letters in Drug Design & Discovery
- Previous Issues
- Volume 21, Issue 16, 2024
Letters in Drug Design & Discovery - Volume 21, Issue 16, 2024
Volume 21, Issue 16, 2024
-
-
A Comprehensive Review of the Advancement in Omic Technologies in the Field of Drug Discovery and Development
Discovering new drugs is time-consuming and expensive and involves many different tools from various domains. Numerous omic technologies, such as genomics, transcriptomics, proteomics, and metabolomics, have been created to speed up the process. Leveraging genetic and genomic insights, these methodologies play a pivotal role. Genetic insights aid in target identification, prioritization, and the prediction of drug out Read More
-
-
-
Anti-tumor Activity of Indole: A Review
Authors: Momen R.F. Mohamed, Mai E. Shoman, Taha F. S. Ali and Gamal El-Din A. Abuo-RahmaGenerally, heterocyclic compounds are included in a large class of pharmacologically active compounds. The indole scaffold in this category is widely distributed in nature and present in many active compounds, especially anti-cancer agents. Due to its unique physicochemical and biological properties, the indole platform has been considered a favorable scaffold in anti-cancer drug design and development. Various indole co Read More
-
-
-
P-glycoproteins in the Pathology and Treatment of Alzheimer's Disease
Alzheimer's disease (AD), a central cause of dementia, is characterized by the accumulation of amyloid β-peptide (Aβ) peptides in the brain. P-glycoprotein (P-gp), a highly expressed protein in the BBB, plays a fundamental role in transporting Aβ from the brain to the blood and protecting the blood-brain barrier (BBB). The dysfunction or decreased abundance of this transporting protein is associated with the accumulation Read More
-
-
-
Ligand-based Molecular Modeling of HDL Receptor SR-BI Inhibitors as Potent Anti-hyperlipidemic Agents
Authors: Swati Verma and Sarvesh PaliwalIntroductionThe High-density lipoprotein (HDL) receptor, Scavenger receptor class B, type I (SRBI) plays a crucial role in lipoprotein metabolism, cholesterol homeostasis, and atherosclerosis. In the present study, a quantitative structure-activity relationship study (QSAR) investigation was conducted on a data set of 31 novel indolinyl thiazole-based inhibitors of SR-BI mediated lipid uptake.MethodsTo build the QSAR model, Read More
-
- Drug Design, Discovery and Therapy, Drug Design & Discovery, Medicinal Chemistry, Pharmacology
-
-
-
Computational Insights on Migraine and Anxiety in Association with BDNF
BackgroundMigraine is an unusual piercing headache on one side of the head. It is due to the dysregulation of epigenetic factors associated with the brain. Migraine affects about one percent of the general population. Despite the recent implementation of worldwide diagnostic criteria for migraine, this disorder remains relatively unknown and is frequently underdiagnosed. Migrainous conditions are also ass Read More
-
-
-
-
Design and Synthesis of Novel Anti-proliferative Formononetin Derivatives
Authors: Zeping Luo, Liwei Pan, XiuJu Yin and Hailin ChenBackgroundThis study aimed to design and synthesize a series of novel C8-Formononetin derivatives and evaluate their in vitro anti-tumor activity. The experimental results showed that these derivatives exhibited varying degrees of anti-tumor effects on HeLa, A549, and HepG2 cells, and compound 8, in particular, showed excellent inhibitory activity against HepG2 cell growth, which surpassed that of 5-FU.MethodsImporta Read More
-
-
-
A Deep Dive into PDE5 Inhibition: Innovative Discoveries via Virtual Screening
Authors: Abhijit Debnath, Hema Chaudhary, Parul Sharma, Rajesh Singh and Shikha SrivastavaBackgroundPDE5 inhibitors have had a surge in popularity over the last decade owing to their efficacy in the treatment of erectile dysfunction, coronary vasculopathy, and pulmonary arterial hypertension. These inhibitors exhibit competitive binding with phosphodiesterase type 5 and inhibit the hydrolysis of cyclic guanosine monophosphate, hence elevating the levels of cGMP in smooth muscle cells and prolonging the durati Read More
-
-
-
Development of Potential Antidiabetic Agents using 2D and 3D QSAR, Molecular Docking and ADME Properties In-silico Studies of α-amylase Inhibitors
More LessBackgroundA series of 2-arylbenzimidazole derivatives were designed and developed as antidiabetic drugs using 2D and 3D QSAR, molecular docking and ADME studies.MethodsAll molecular modeling studies were performed using Molecular Design Suite V-Life MDS software. New chemical entities (NCEs) were designed based on the results of 2D and 3D QSAR studies. Docking studies were performed with the desig Read More
-
-
-
QSAR Analysis and Molecular Docking Studies of Aryl Sulfonamide Derivatives as Mcl-1 Inhibitors and the Influence of Structure and Chirality on the Inhibitory Activity
Authors: Jia Chen, Yang Ma, Jian-Wei Zou, Sheng Hu, Meilan Huang and Guixiang HuBackgroundMcl-1 is a kind of antiapoptotic protein and its overexpression is closely related to the occurrence of cancer. Aryl sulfonamide derivatives are expected to become new anticancer agents due to their high inhibitory activity on the Mcl-1 protein.ObjectiveThe study aimed to establish the QSAR model with good prediction ability and elaborate the influence of structure and chirality on the inhibitory activity.Met Read More
-
-
-
In Silico Structure-based Screening of Potential Anticancer Bioactive Natural Constituents from African Natural Products
IntroductionInhibitors of topoisomerases, essential regulators of cancer development, are promising as cancer treatments. These enzymes regulate DNA topology and eliminate topological constraints during various biological processes, including replication, transcription, and recombination. Nature has continually offered scientists pathways to explore the development of new drugs. Indeed, since ancient times Read More
-
-
-
Predicting the Pharmacological Targets of Astragalus membranaceus against Hypertensive Nephropathy
Authors: Ningxin Zhang, Chen Guan, Lingyu Xu, Zengying Liu, Chenyu Li, Quandong Bu, Xuefei Shen and Yan XuObjectiveHypertension is one of the main causes of chronic kidney disease. Astragalus membranaceus (AM), an important traditional Chinese medicine for treating hypertensive nephropathy, has a complex composition that makes it challenging to explore its mechanism of action and limits its clinical application. This study aims to investigate the underlying mechanism of AM in treating hypertensive nephropathy.MethodsWe Read More
-
-
-
Design and Biological Evaluation of Cephalosporin based Metallo-β-lactamase (MBL) Inhibitors#
BackgroundPrevalence of microbial resistance due to Metallo-β-lactamase (MBL) enzyme pose a serious threat to human life. MBLs depend on active site zinc for their hydrolytic activity; hence, the investigation of zinc chelators emerged as an attractive strategy for the development of potent MBL inhibitors.MethodsTo prove that such chelators selectively target MBLs, in the present investigation, novel cephalosporins ba Read More
-
-
-
Fluconazole Microemulsions: Preparation, Statistical Optimization by Two-level Factorial Design, and Physicochemical Evaluation
BackgroundCandida albicans is the yeast that causes the fungal infection known as candidiasis. One of the standard methods for treating candida is the application of fluconazole. The low solubility of fluconazole in aqueous media is a big problem in the use of this agent. Novel drug delivery systems, such as microemulsions, could be applied to solve this problem. The main aim of this study was to perform statistical optimizati Read More
-
-
-
Effects of Compound in Hedyotis diffusa Willd against Acute Myeloid Leukemia: An In Silico and In Vitro Study
Authors: Chunyi Lyu, Xuewei Yin, Zonghong Li, Teng Wang and Ruirong XuBackgroundHedyotis diffusa Willd (HDW) is an herb that has been used empirically for treating cancer, and its antileukemic effect has been confirmed by laboratory evidence. This study aimed to explore the underlying mechanism by which HDW and its active compound exert effects on acute myeloid leukemia (AML) through in silico analyses combined with experimental validation.MethodsThe targets of the compounds Read More
-
-
-
Exploring and Designing Potential Inhibitors of SIRT2 in Natural Products by Artificial Intelligence (AI) and Molecular Dynamics Methods
Authors: Yangyang Ni, Juxia Bai, Yuqi Zhang, Haoran Qiao, Liqun Liang, Junfeng Wan, Yanyan Zhu, Haijing Cao, Huiyu Li and Qingjie ZhaoBackgroundThe histone deacetylase family of proteins, which includes the sirtuins, participates in a wide range of cellular processes, and is intimately involved in neurodegenerative illnesses. The research on sirtuins has garnered a lot of interest. However, there are currently no effective therapeutic drugs.MethodsIn order to explore the potential inhibitors of SIRTs, we first screened four potential lead compounds of SIRT2 i Read More
-
-
-
Synthesis, Antiproliferative Evaluation, and Molecular Docking of Thieno[3,2-e]indazole Derivatives
Authors: Rafat M. Mohareb, Ibram Refat Mikhail, Marwa Soliman Gamaan and Ensaf S. AlwanBackgroundAlthough indazole derivatives are rare and may not be available easily in nature, there are many reports demonstrating their pharmaceutical and other applications.ObjectiveThis study aimed to synthesize new indazole derivatives and evaluate their anti-proliferative activity to produce new anti-cancer agents.MethodsCompounds 3a-c were synthesized through the reaction. The 2-aryllidenecyclohexane-1,3-di Read More
-
-
-
A Linear and Nonlinear QSAR Analysis of Benzimidazole Derivative XY123 in Prostate Cancer Treatment
Authors: Bing Li and Xiaoqiang LiuBackgroundMetastatic Castration-resistant Prostate Cancer (mCRPC) represents a critical challenge in current prostate cancer treatment. Benzimidazole Derivative XY123 has emerged as a novel inhibitor for its treatment.ObjectiveThis study aims to establish a robust Quantitative Structure-Activity Relationship (QSAR) model for predicting the activity of Benzimidazole Derivative XY123 derivatives, aiding the develo Read More
-
-
-
Design, Synthesis, and In vitro Biological Activities of Matrine Skeleton Derivatives as Potential Cancer Inhibitors
Authors: Bin Zhou, Lisheng Wang, Yongquan Wei, Meiyan Jiang and Xingdong WangBackgroundThirteen derivatives were designed and synthesized based on the excellent lead compound Matrine.ObjectiveThis study aimed to discover novel anticancer agents with superior anticancer activity and to support the discovery of new drugs.MethodsThe in vitro antiproliferative activity of all derivatives against four human cancer cells, A549, HGC-27, HCT-116, and HeLa, was determined by MTT. The best active c Read More
-
-
-
Structural Insights into Mouse β3-adrenergic Receptor: A Promising Target for Obesity and Diabetes Therapeutics
Authors: Vijayalakshmi Gangadhara, Kavishankar Gawli and Asha AbrahamBackgroundInvestigating the structural attributes of the murine beta3-adrenergic receptor (β3-AR) is imperative for comprehending metabolic regulation, given its close resemblance to the human β3-AR. This receptor holds promise as a target for novel drug development against obesity and diabetes. Despite its potential, the absence of knowledge regarding the structure of murine β3-AR hampers a comprehensive under Read More
-
- Drug Design, Discovery and Therapy, Drug Design & Discovery, Medicinal Chemistry, Pharmacology
-
-
-
Do Anticancer Medicinal Compounds have DNMT1 Regulating Activity: An In silico Investigation
Authors: Fahad Hassan Shah and Song Ja KimBackgroundDNA methyltransferases (DNMTs) are a group of epigenetic enzymes implicated in regulating gene expression in actively dividing cells. Among these enzymes, DNMT1 plays a leading role in causing increased DNA methylation of tumor suppressors and other genes in cancer cells. This methylation event disrupts the cell cycle regulating genes, allowing an uninterrupted proliferation of cancer cells, Read More
-
-
- Medicine, Neurology, Pharmacology, Neuroscience
-
Volumes & issues
-
Volume 21 (2024)
-
Volume 20 (2023)
-
Volume 19 (2022)
-
Volume 18 (2021)
-
Volume 17 (2020)
-
Volume 16 (2019)
-
Volume 15 (2018)
-
Volume 14 (2017)
-
Volume 13 (2016)
-
Volume 12 (2015)
-
Volume 11 (2014)
-
Volume 10 (2013)
-
Volume 9 (2012)
-
Volume 8 (2011)
-
Volume 7 (2010)
-
Volume 6 (2009)
-
Volume 5 (2008)
-
Volume 4 (2007)
-
Volume 3 (2006)
-
Volume 2 (2005)
-
Volume 1 (2004)
Most Read This Month
Article
content/journals/lddd
Journal
10
5
false
en
